| Davey M Perrin, MD | |
|
206 S Clay St Ste A, Ennis, TX 75119-4530 | |
| (903) 229-4292 | |
| (903) 229-4288 |
| Full Name | Davey M Perrin |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 206 S Clay St Ste A, Ennis, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518057439 | NPI | - | NPPES |
| 4301086588 | Other | MI | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301086588 (Michigan) | Secondary |
| 207Q00000X | Family Medicine | N4662 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Temple, TX | Home health agency |
| Jordan Health Services | Palestine, TX | Home health agency |
| V Care Home Health Inc | The colony, TX | Home health agency |
| Infinite Care Home Health Inc | Waxahachie, TX | Home health agency |
| New Century Hospice Of Dallas | Dallas, TX | Hospice |
| Navarro Regional Hospital | Corsicana, TX | Hospital |
| Baylor Scott & White Medical Center- Waxahachie | Waxahachie, TX | Hospital |
| Ennis Regional Medical Center | Ennis, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davey M Perrin Md | 6002273026 | 2 |
News Archive
The NCD Alliance has welcomed More Active People for a Healthier World, the new WHO Global Action Plan for Physical Activity 2018-2030, launched today in Lisbon, saying it has the potential to prevent huge numbers of deaths and disability from noncommunicable diseases across the globe.
An $18 million commitment from the Simms/Mann Family Foundation, led by Dr. Victoria Mann Simms and Ronald Simms, will support UCLA's expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.
By broadly comparing the DNA of children to that of elderly people, gene researchers have identified gene variants that influence lifespan, either by raising disease risk or by providing protection from disease.
› Verified 3 days ago
| Entity Name | Davey M Perrin Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043443054 PECOS PAC ID: 6002273026 Enrollment ID: O20230607001515 |
News Archive
The NCD Alliance has welcomed More Active People for a Healthier World, the new WHO Global Action Plan for Physical Activity 2018-2030, launched today in Lisbon, saying it has the potential to prevent huge numbers of deaths and disability from noncommunicable diseases across the globe.
An $18 million commitment from the Simms/Mann Family Foundation, led by Dr. Victoria Mann Simms and Ronald Simms, will support UCLA's expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.
By broadly comparing the DNA of children to that of elderly people, gene researchers have identified gene variants that influence lifespan, either by raising disease risk or by providing protection from disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Davey M Perrin, MD 206 S Clay St Ste A, Ennis, TX 75119-4530 Ph: (903) 229-4292 | Davey M Perrin, MD 206 S Clay St Ste A, Ennis, TX 75119-4530 Ph: (903) 229-4292 |
News Archive
The NCD Alliance has welcomed More Active People for a Healthier World, the new WHO Global Action Plan for Physical Activity 2018-2030, launched today in Lisbon, saying it has the potential to prevent huge numbers of deaths and disability from noncommunicable diseases across the globe.
An $18 million commitment from the Simms/Mann Family Foundation, led by Dr. Victoria Mann Simms and Ronald Simms, will support UCLA's expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.
By broadly comparing the DNA of children to that of elderly people, gene researchers have identified gene variants that influence lifespan, either by raising disease risk or by providing protection from disease.
› Verified 3 days ago
Dr. John Bruno Arkusinski, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 S Clay St Ste A, Ennis, TX 75119 Phone: 469-256-2525 Fax: 469-256-2164 | |
Thomas Tran, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2203 W Ennis Ave, Suite 300, Ennis, TX 75119 Phone: 972-875-2858 Fax: 972-875-2928 | |
Dr. Fredric Clark Puckett, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2203 W Lampasas St, Suite 205, Ennis, TX 75119 Phone: 972-875-6200 Fax: 972-875-6414 | |
Dr. Stefanie Nicole Rust, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 West Lampasas Street, Ennis, TX 75119 Phone: 972-875-0900 Fax: 469-256-2154 | |
Dr. Danny Blayne Laws, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 717 W Lampasas St, Ennis, TX 75119 Phone: 972-875-6700 | |
Dr. Bill Ray Lee, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2203 W Lampasas St, Suite 211, Ennis, TX 75119 Phone: 972-875-3997 Fax: 972-875-2545 | |
Dr. Raymond Wesley Blair Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2203 W Lampasas St Ste 101, Ennis, TX 75119 Phone: 972-875-7799 Fax: 972-878-3031 |